Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxychloroquine for COVID-19
RBR-3k4wxbPhase 2Not yet recruiting
- Sponsor
- Hospital Santo Antônio
- Start
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of hydroxychloroquine and azithromycin in coronavirus disease 2019 (COVID-19) (3 arms), sponsored by Hospital Santo Antônio. Planned start May 2020; status: not yet recruiting.
02
Drugs
hydroxychloroquineazithromycin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on RBR-3k4wxb.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-3k4wxb.